News
ViroPharma Announces Publication of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Phase 3 Trial Result PR-USA.net
View ArticleViroPharma hopes deal will bring subcutaneous form of Cinryze
ViroPharma hopes deal will bring subcutaneous form of Cinryze Bizjournals.com
View ArticleShire's Firazyr effective for hereditary angiodema, FDA says
Shire's Firazyr effective for hereditary angiodema, FDA says Pharma Times, UK
View ArticleShire wins FDA approval for rare disease drug
Shire wins FDA approval for rare disease drug Bizjournals.com
View ArticleDyax announces partnership with taiba for Kalbitor
Dyax announces partnership with taiba for Kalbitor The Fly on the Wall
View ArticleDyax And ViroPharma: An Overview Of HAE Space
Dyax And ViroPharma: An Overview Of HAE Space Seeking Alpha
View ArticleViroPharma, Halozyme Rise After FDA Issue Cleared Up
ViroPharma, Halozyme Rise After FDA Issue Cleared Up Investors.com
View ArticleSpec Stock: Cramer Profiles an Orphan Drug Maker (video)
Spec Stock: Cramer Profiles an Orphan Drug Maker (video) CNBC
View ArticleAn Interesting Bio Play in the Blood Disorder Niche
An Interesting Bio Play in the Blood Disorder Niche Motley Fool
View ArticleBioCryst's immune disorder drug succeeds in mid-stage trial
BioCryst's immune disorder drug succeeds in mid-stage trial Yahoo/Reuters
View ArticleSalix, Pharming Group announces FDA approval of Ruconest
Salix, Pharming Group announces FDA approval of Ruconest Yahoo/Fly on the Wall
View Article
